Lucy Mae Spurgeon
Lucy Mae Spurgeon
Rogelio Perez,Christopher W Chan,Aakash Reddy et al.
Rogelio Perez et al.
Olga M Nardone,Silvio Danese,Beatriz Gros et al.
Olga M Nardone et al.
Vedolizumab treatment outcomes in early versus late Crohn's disease - Authors' reply [0.03%]
vedolizumab治疗早期与晚期克罗恩病的效果作者回应
Geert R D&#x;Haens,Lotte Oldenburg,Melanie S Hulshoff;LOVE-CD collaborators
Geert R D&#x;Haens
Vedolizumab treatment outcomes in early versus late Crohn's disease [0.03%]
vedolizumab治疗早期与晚期克罗恩病的效果
Rirong Chen,Kenneth Croitoru,Sun-Ho Lee
Rirong Chen
Vedolizumab treatment outcomes in early versus late Crohn's disease [0.03%]
vedolizumab治疗早期与晚期克罗恩病的效果差异
Nurulamin M Noor,Ailsa L Hart,James C Lee et al.
Nurulamin M Noor et al.
Antipruritic effects of the ileal bile acid transporter inhibitor linerixibat [0.03%]
胆汁酸转运体抑制剂linerixibat的止痒作用
Gideon M Hirschfield,Andreas E Kremer,Cynthia Levy
Gideon M Hirschfield
Viral hepatitis in Roma communities: vulnerabilities and improving care access [0.03%]
罗姆人社区的病毒性肝炎：脆弱性和改善护理访问途径
Pavol Kristian,Ivana Hockickova,Monika Halanova et al.
Pavol Kristian et al.
The Lancet Gastroenterology Hepatology
The Lancet Gastroenterology Hepatology